Inventor
MANINI PETER
CH26 patents
⚠️ This page may combine multiple inventors who share the name “MANINI PETER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HELSINN HEALTHCARE SA
13 patentsUS9403867B2Aug 2, 2016
Methods of producing anamorelin hydrochloride having controlled chloride content
HELSINN HEALTHCARE SA9 citations90
US9981002B2May 29, 2018
Methods of producing anamorelin hydrochloride having controlled chloride content
HELSINN HEALTHCARE SA3 citations82
US9956261B2May 1, 2018
Methods of producing anamorelin hydrochloride having controlled chloride content
HELSINN HEALTHCARE SA3 citations82
US9872883B2Jan 23, 2018
Methods of producing anamorelin hydrochloride having controlled chloride content
HELSINN HEALTHCARE SA3 citations82
US10208073B2Feb 19, 2019
Solution comprising the chloride hydrochloride salt of 4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-IUM-(fosnetupitant) and palonosetron hydrochloride in combination with dexamethasone as a neurokinin receptor modulator
HELSINN HEALTHCARE SA2 citations72
US9403772B2Aug 2, 2016
4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-ium as a neurokinin receptor modulator
HELSINN HEALTHCARE SA4 citations72
US10300105B2May 28, 2019
Methods of producing anamorelin hydrochloride having controlled chloride content
HELSINN HEALTHCARE SA1 citations71
US12071421B2Aug 27, 2024
Process for the synthesis of substituted chloromethyl dialkylphosphates
HELSINN HEALTHCARE SA0 citations61
US11312698B2Apr 26, 2022
Fosnetupitant chloride hydrochloride having improved stability
HELSINN HEALTHCARE SA0 citations61
US10905737B2Feb 2, 2021
Methods of producing anamorelin hydrochloride having controlled chloride content
HELSINN HEALTHCARE SA0 citations60
US10717721B2Jul 21, 2020
Substituted piperaziniums for the treatment of emesis
HELSINN HEALTHCARE SA0 citations51
US9908907B2Mar 6, 2018
Substituted piperaziniums for the treatment of emesis
HELSINN HEALTHCARE SA0 citations51
US10576122B2Mar 3, 2020
Methods of producing anamorelin hydrochloride having controlled chloride content
HELSINN HEALTHCARE SA0 citations50
OCERA THERAPEUTICS INC
7 patentsUS9604909B2Mar 28, 2017
L-ornithine phenyl acetate and methods of making thereof
OCERA THERAPEUTICS INC23 citations97
US9034925B2May 19, 2015
L-ornithine phenyl acetate and methods of making thereof
OCERA THERAPEUTICS INC27 citations95
US8785498B2Jul 22, 2014
L-ornithine phenyl acetate and methods of making thereof
OCERA THERAPEUTICS INC27 citations95
US9260379B2Feb 16, 2016
Methods of making L-ornithine phenyl acetate
OCERA THERAPEUTICS INC24 citations93
US10173964B2Jan 8, 2019
L-ornithine phenyl acetate and methods of making thereof
OCERA THERAPEUTICS INC9 citations91
US11161802B2Nov 2, 2021
L-ornithine phenyl acetate and methods of making thereof
OCERA THERAPEUTICS INC3 citations83
US10550069B2Feb 4, 2020
L-ornithine phenyl acetate and methods of making thereof
OCERA THERAPEUTICS INC6 citations83